Corporate Crime ObservatoryAug 27, 20231 minCSR BLOG: THE ASPARTAME DEBATE: ARE ECONOMIC INTERESTS CLOUDING THE TRUTH?
Corporate Crime ObservatoryMar 30, 20232 minTHE COST OF MANIPULATION: THE IRRESPONSIBLE ABUSE OF TECHNOLOGICAL OPACITY IN BIG PHARMA
Dr. Costantino GrassoSep 29, 20222 minPARTICIPATION IN PADOVA SUMMER SCHOOL ON CORPORATE SUSTAINABILITY